Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance

被引:57
作者
Schwarcz, Leilani [1 ]
Chen, Miao-Jung [2 ]
Vittinghoff, Eric [3 ]
Hsu, Ling [2 ]
Schwarcz, Sandra [2 ,3 ]
机构
[1] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA
[2] San Francisco Dept Publ Hlth, HIV Epidemiol Sect, AIDS Off, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
关键词
AIDS; AIDS-defining illness; AIDS-related opportunistic illness; anti-HIV agents; HAART; highly active antiretroviral therapy; HIV; incidence; SARCOMA-ASSOCIATED HERPESVIRUS; ACTIVE ANTIRETROVIRAL THERAPY; INFECTIOUS-DISEASES-SOCIETY; KAPOSIS-SARCOMA; HIV; VIRUS; ERA; RECOMMENDATIONS; INDIVIDUALS; PREDICTORS;
D O I
10.1097/QAD.0b013e32835b0fa2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To measure the incidence and risk factors of AIDS-defining opportunistic illnesses (AOIs) in the pre-highly active antiretroviral therapy (HAART) (1993-1995), early-HAART (1996-2000), and late-HAART (2001-2008) periods. Design: Prospective cohort analysis of AIDS surveillance data. Methods: Individuals living with, or diagnosed with AIDS from 1993 through 2008 were included. Poisson regression models were used to estimate annual incidence rates of the eight most frequently occurring AOIs, and to compare these rates in the pre-HAART (1993-1995), early-HAART (1996-2000), and late-HAART (2001-2008) periods. Results: There were 18 733 individuals with AIDS included; 5788 were diagnosed prior to 1993 and 12 945 were diagnosed between 1 January 1993 and 31 December 2008. The incidence rates of Pneumocystis jiroveci pneumonia, wasting syndrome, Kaposi's sarcoma, HIV encephalopathy, cytomegalovirus retinitis, cytomegalovirus, and esophageal candidiasis decreased during the study period, with the largest declines observed between the pre-HAART and early-HAART periods. Incidence rates also decreased between the early-HAART and late-HAART periods, though not as sharply. Incidence rate reductions between the earliest and latest period ranged from 84 to 99%. Conclusions: Steep declines in incidence of AOIs were found following the introduction of HAART and continued into the late-HAART era. These declines reflect the impact of HIV diagnosis and treatment on a population level. (C) 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins AIDS 2013, 27:597-605
引用
收藏
页码:597 / 605
页数:9
相关论文
共 39 条
[1]   Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy [J].
Bhaskaran, Krishnan ;
Mussini, Cristina ;
Antinori, Andrea ;
Walker, Ann Sarah ;
Dorrucci, Maria ;
Sabin, Caroline ;
Phillips, Andrew ;
Porter, Kholoud .
ANNALS OF NEUROLOGY, 2008, 63 (02) :213-221
[2]   Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy [J].
Brodt, HR ;
Kamps, BS ;
Gute, P ;
Knupp, B ;
Staszewski, S ;
Helm, EB .
AIDS, 1997, 11 (14) :1731-1738
[3]   AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study [J].
Buchacz, Kate ;
Baker, Rose K. ;
Palella, Frank J., Jr. ;
Chmiel, Joan S. ;
Lichtenstein, Kenneth A. ;
Novak, Richard M. ;
Wood, Kathleen C. ;
Brooks, John T. .
AIDS, 2010, 24 (10) :1549-1559
[4]  
CDC, 2012, HIV US GLANC, P1
[5]  
CDC, 1993, MORB MORTAL WKLY REP, V41
[6]  
CDC, 1999, MORB MORTAL WKLY REP, P48
[7]  
CDC, 1998, MMWR-MORBID MORTAL W, V10, P43
[8]  
CDC, 1993, 1993 REV CLASS SYST
[9]   Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis [J].
Detels, R ;
Tarwater, P ;
Phair, JP ;
Margolick, J ;
Riddler, SA ;
Muñoz, A .
AIDS, 2001, 15 (03) :347-355
[10]  
Dore GJ, 2002, J ACQ IMMUN DEF SYND, V29, P388, DOI 10.1097/00126334-200204010-00010